Cooper EBITDA Margin 2010-2024 | COO
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Cooper (COO) over the last 10 years. The current EBITDA margin for Cooper as of January 31, 2024 is .
| Cooper EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| 2024-01-31 |
$3.67B |
$0.91B |
24.85% |
| 2023-10-31 |
$3.59B |
$0.90B |
25.05% |
| 2023-07-31 |
$3.51B |
$0.86B |
24.59% |
| 2023-04-30 |
$3.43B |
$0.84B |
24.51% |
| 2023-01-31 |
$3.38B |
$0.88B |
26.01% |
| 2022-10-31 |
$3.31B |
$0.85B |
25.79% |
| 2022-07-31 |
$3.22B |
$0.87B |
26.93% |
| 2022-04-30 |
$3.14B |
$0.83B |
26.28% |
| 2022-01-31 |
$3.03B |
$0.82B |
27.07% |
| 2021-10-31 |
$2.92B |
$0.82B |
27.92% |
| 2021-07-31 |
$2.85B |
$0.79B |
27.65% |
| 2021-04-30 |
$2.66B |
$0.75B |
28.18% |
| 2021-01-31 |
$2.47B |
$0.63B |
25.39% |
| 2020-10-31 |
$2.43B |
$0.60B |
24.64% |
| 2020-07-31 |
$2.44B |
$0.64B |
26.18% |
| 2020-04-30 |
$2.54B |
$0.71B |
27.89% |
| 2020-01-31 |
$2.67B |
$0.83B |
31.07% |
| 2019-10-31 |
$2.65B |
$0.83B |
31.21% |
| 2019-07-31 |
$2.61B |
$0.80B |
30.77% |
| 2019-04-30 |
$2.59B |
$0.78B |
29.92% |
| 2019-01-31 |
$2.57B |
$0.70B |
27.30% |
| 2018-10-31 |
$2.53B |
$0.68B |
26.81% |
| 2018-07-31 |
$2.44B |
$0.64B |
26.28% |
| 2018-04-30 |
$2.34B |
$0.62B |
26.38% |
| 2018-01-31 |
$2.23B |
$0.64B |
28.52% |
| 2017-10-31 |
$2.14B |
$0.62B |
28.89% |
| 2017-07-31 |
$2.10B |
$0.58B |
27.86% |
| 2017-04-30 |
$2.06B |
$0.58B |
28.03% |
| 2017-01-31 |
$2.02B |
$0.55B |
27.32% |
| 2016-10-31 |
$1.97B |
$0.52B |
26.58% |
| 2016-07-31 |
$1.91B |
$0.49B |
25.88% |
| 2016-04-30 |
$1.85B |
$0.45B |
24.03% |
| 2016-01-31 |
$1.80B |
$0.42B |
23.46% |
| 2015-10-31 |
$1.80B |
$0.43B |
23.80% |
| 2015-07-31 |
$1.81B |
$0.42B |
23.09% |
| 2015-04-30 |
$1.78B |
$0.44B |
24.89% |
| 2015-01-31 |
$1.76B |
$0.45B |
25.50% |
| 2014-10-31 |
$1.72B |
$0.45B |
25.92% |
| 2014-07-31 |
$1.66B |
$0.46B |
27.51% |
| 2014-04-30 |
$1.64B |
$0.45B |
27.61% |
| 2014-01-31 |
$1.61B |
$0.44B |
27.53% |
| 2013-10-31 |
$1.59B |
$0.43B |
27.14% |
| 2013-07-31 |
$1.57B |
$0.45B |
28.44% |
| 2013-04-30 |
$1.54B |
$0.43B |
27.76% |
| 2013-01-31 |
$1.50B |
$0.41B |
27.15% |
| 2012-10-31 |
$1.45B |
$0.40B |
27.34% |
| 2012-07-31 |
$1.41B |
$0.38B |
26.81% |
| 2012-04-30 |
$1.38B |
$0.35B |
25.31% |
| 2012-01-31 |
$1.36B |
$0.34B |
25.09% |
| 2011-10-31 |
$1.33B |
$0.33B |
24.51% |
| 2011-07-31 |
$1.28B |
$0.32B |
24.88% |
| 2011-04-30 |
$1.23B |
$0.32B |
25.84% |
| 2011-01-31 |
$1.19B |
$0.30B |
24.85% |
| 2010-10-31 |
$1.16B |
$0.28B |
24.53% |
| 2010-07-31 |
$1.13B |
$0.27B |
23.49% |
| 2010-04-30 |
$1.12B |
$0.25B |
22.02% |
| 2010-01-31 |
$1.09B |
$0.25B |
22.50% |
| 2009-10-31 |
$1.08B |
$0.24B |
22.50% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$17.874B |
$3.593B |
|
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
|
